tiprankstipranks
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market
MDMA
PharmAla Biotech Holdings, Inc.
RESEARCH TOOLSreports

PharmAla Biotech Holdings, Inc. (MDMA) Cash flow

64 Followers

PharmAla Biotech Holdings, Inc. Cash Flow

TSE:MDMA's free cash flow for Q4 2025 was C$-297.86K. For the 2025 fiscal year, TSE:MDMA's free cash flow was decreased by C$-498.83K and operating cash flow was C$-294.94K. See a summary of the company’s cash flow.
Cash Flow
Nov 25Nov 24Nov 23Nov 22Aug 21
Operating Cash Flow
C$ -1.04MC$ -321.36KC$ -339.66KC$ -625.37KC$ -173.57K
Investing Cash Flow
C$ -935.27KC$ -226.42KC$ -506.74KC$ -994.87KC$ 629.22K
Financing Cash Flow
C$ 1.60MC$ 772.12KC$ 189.29KC$ 0.00C$ 2.02M
End Cash Position
C$ 40.19KC$ 419.38KC$ 195.04KC$ 852.14KC$ 2.47M
Free Cash Flow
C$ -1.05MC$ -547.78KC$ -846.39KC$ -1.62MC$ -435.76K
Currency in CAD

PharmAla Biotech Holdings, Inc. Cash Flow